Pretty sure i remember seeing this study a while back though but thanks for the reminder!
not sure why they are bothering though? It's high dose oral form and we all know about elmiron and pigmentary maculopathy etc Nd all the court cases..
Plus our patents would prohibit the use of pps in this area..
Who is supplying the PPS?
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-4107
-
- There are more pages in this discussion • 299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.5¢ |
Change
0.020(8.51%) |
Mkt cap ! $89.19M |
Open | High | Low | Value | Volume |
23.5¢ | 25.5¢ | 23.5¢ | $161.2K | 660.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 77422 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 15109 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 72422 | 0.250 |
3 | 402284 | 0.240 |
3 | 49455 | 0.235 |
8 | 216656 | 0.230 |
4 | 57500 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 15109 | 1 |
0.260 | 58362 | 1 |
0.270 | 20000 | 2 |
0.275 | 13636 | 2 |
0.280 | 223933 | 8 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online